Group One Trading’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Sell
283,821
-58,243
-17% -$522K ﹤0.01% 1949
2026
Q1
$2.78M Sell
342,064
-132,513
-28% -$1.2M 0.01% 1775
2025
Q4
$3.19M Buy
474,577
+96,335
+25% +$726K 0.01% 1860
2025
Q3
$3.28M Sell
378,242
-479,044
-56% -$3.73M 0.01% 1868
2025
Q2
$5.4M Buy
857,286
+235,215
+38% +$1.56M 0.01% 1274
2025
Q1
$3.99M Buy
+622,071
New +$5.14M 0.01% 1252
2024
Q4
Sell
-30,610
Closed -$295K 7743
2024
Q3
$387K Sell
30,610
-139,144
-82% -$1.8M ﹤0.01% 3055
2024
Q2
$2.15M Buy
+169,754
New +$1.71M 0.01% 1393
2022
Q3
Sell
-188,061
Closed -$8.15M 8014
2022
Q2
$9.67M Sell
188,061
-11,209
-6% -$581K 0.02% 863
2022
Q1
$14.7M Buy
199,270
+98,798
+98% +$8.81M 0.01% 762
2021
Q4
$14.4M Buy
100,472
+31,603
+46% +$5.43M 0.01% 850
2021
Q3
$14.3M Sell
68,869
-50,474
-42% -$11.1M 0.02% 817
2021
Q2
$25.3M Buy
119,343
+75,171
+170% +$13.8M 0.03% 503
2021
Q1
$8.01M Buy
44,172
+37,213
+535% +$7.42M 0.01% 1113
2020
Q4
$776K Sell
6,959
-33,480
-83% -$3.56M ﹤0.01% 2870
2020
Q3
$4.38M Sell
40,439
-23,325
-37% -$2.84M 0.01% 1007
2020
Q2
$5.32M Buy
63,764
+63,471
+21,662% +$2.43M 0.02% 770
2020
Q1
$4K Sell
293
-64,109
-100% -$542K ﹤0.01% 4837
2019
Q4
$256K Buy
+64,402
New +$279K ﹤0.01% 2985
2019
Q1
Sell
-20,701
Closed -$654K 5190
2018
Q4
$762K Buy
20,701
+3,074
+17% +$119K 0.01% 1705
2018
Q3
$663K Buy
17,627
+3,920
+29% +$110K 0.01% 2032
2018
Q2
$367K Buy
+13,707
New +$463K ﹤0.01% 2562
2018
Q1
Sell
-1,314
Closed -$52.8K 5170
2017
Q4
$33K Sell
1,314
-446
-25% -$10.9K ﹤0.01% 3942
2017
Q3
$40K Sell
1,760
-491
-22% -$11K ﹤0.01% 3749
2017
Q2
$52K Sell
2,251
-3,770
-63% -$74K ﹤0.01% 3492
2017
Q1
$154K Sell
6,021
-20,543
-77% -$565K ﹤0.01% 2702
2016
Q4
$669K Sell
26,564
-29,444
-53% -$859K 0.01% 1585
2016
Q3
$2.33M Buy
56,008
+51,106
+1,043% +$6.6M 0.03% 772
2016
Q2
$713K Sell
4,902
-10,808
-69% -$1.24M 0.01% 1470
2016
Q1
$1.62M Sell
15,710
-7,320
-32% -$785K 0.02% 898
2015
Q4
$3.86M Sell
23,030
-3,322
-13% -$511K 0.05% 484
2015
Q3
$3.73M Buy
26,352
+11,442
+77% +$2.57M 0.05% 462
2015
Q2
$3.32M Buy
14,910
+6,054
+68% +$1.06M 0.05% 486
2015
Q1
$1.47M Buy
8,856
+5,654
+177% +$918K 0.02% 809
2014
Q4
$380K Sell
3,202
-6,772
-68% -$708K 0.01% 1772
2014
Q3
$832K Sell
9,974
-916
-8% -$82.8K 0.01% 1237
2014
Q2
$1.01M Sell
10,890
-3,008
-22% -$264K 0.02% 1134
2014
Q1
$1.26M Buy
13,898
+9,982
+255% +$1.12M 0.02% 913
2013
Q4
$401K Sell
3,916
-3,800
-49% -$268K 0.01% 1834
2013
Q3
$488K Buy
7,716
+5,891
+323% +$332K 0.01% 1626
2013
Q2
$75K Buy
+1,825
New +$79.1K ﹤0.01% 3077

Other funds holding NVAX

Group One Trading's NVAX Position: Q2 2026 in Review

Group One Trading reduced its Novavax (NVAX) stake by 17% in Q2 2026, selling an estimated $522K and leaving 283,821 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1949.

Group One Trading first reported a position in NVAX in Q2 2013 and has held it in 41 quarters since. The position peaked at $25.3M in Q2 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Group One Trading held 283,821 shares of Novavax worth $2.67M as of Q2 2026.
  • Group One Trading sold 58,243 Novavax shares in Q2 2026, an estimated $522K.
  • Novavax made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #1949 holding.
  • Group One Trading first reported a position in Novavax in Q2 2013 and has held it in 41 quarters since.
  • Group One Trading's Novavax position peaked at $25.3M in Q2 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.